Roxana Rustomjee

6.8k citations

44 papers · 4.0k indexed · 1 hit paper · h-index 22

Impact in

Infectious Diseases top 0.2%
- Tuberculosis Research and Epidemiology
Epidemiology top 0.5%
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections

Papers in ⓘ

Infectious Diseases 38
- Tuberculosis Research and Epidemiology 33
- SARS-CoV-2 and COVID-19 Research 3
Epidemiology 26
- Pneumocystis jirovecii pneumonia detection and treatment 16
- Pneumonia and Respiratory Infections 10
- Mycobacterium research and diagnosis 9

Co-authors: Jenny Allen (3 shared papers)Sean M. O’Brien (1 shared paper)Doris Hillemann (1 shared paper)David Alland (1 shared paper)Ana Milovic (1 shared paper)Camilla Rodrigues (1 shared paper)David H. Persing (1 shared paper)Eduardo Gotuzzo (1 shared paper)
Journals: Antimicrobial Agents and Chemotherapy (8 papers)The Lancet Infectious Diseases (6 papers)The Journal of Infectious Diseases (4 papers)Tuberculosis (3 papers)PLoS ONE (3 papers)
Partner nations: South Africa United States United Kingdom

In The Last Decade

Roxana Rustomjee

43 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Rapid Molecular Detection of Tuberculosis and Rifampin Resistance 2010 · 1.6k citations

Peers

Countries citing papers authored by Roxana Rustomjee

Since Specialization

Citations

This map shows the geographic impact of Roxana Rustomjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana Rustomjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana Rustomjee more than expected).

Fields of papers citing papers by Roxana Rustomjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxana Rustomjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana Rustomjee. The network helps show where Roxana Rustomjee may publish in the future.

Co-authors

The 25 scholars most cited alongside Roxana Rustomjee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roxana Rustomjee Line = papers co-authored together Roxana Rustomjee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Rapid Molecular Detection of Tuberculosis and Rifampin Resistance New England Journal of Medicine ·Catharina Boehme, Pamela Nabeta, Doris Hillemann, Mark P. Nicol, Shubhada Shenai, Fiorella Krapp, Jenny Allen, Rasim Tahirli, Robert Blakemore, Roxana Rustomjee, Ana Milovic, Martin Jones, Sean M. O’Brien, David H. Persing, Sabine Ruesch-Gerdes, Eduardo Gotuzzo, Camilla Rodrigues, David Alland, Mark D. Perkins Hit paper breakdown →	2010	1639
2	A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis New England Journal of Medicine ·Corinne Merle, Katherine Fielding, Omou Bah Sow, M. Gninafon, Mame Bocar Lo, Thuli Mthiyane, Joseph Odhiambo, Evans Amukoye, Boubacar Bah, Ferdinand Kassa, Alimatou N′Diaye, Roxana Rustomjee, Bouke C. de Jong, John Horton, Christian Perronne, Charalambos Sismanidis, Olivier Lapujade, Piero Olliaro, Christian Lienhardt	2014	262
3	Host-directed therapies for infectious diseases: current status, recent progress, and future prospects The Lancet Infectious Diseases ·Alimuddin Zumla, Martin Rao, Robert S. Wallis, Stefan H. E. Kaufmann, Roxana Rustomjee, Peter Mwaba, Cristina Vilaplana, Dorothy Yeboah‐Manu, Jeremiah Chakaya, Giuseppe Ippolito, Esam I. Azhar, Michael Höelscher, Markus Maeurer	2016	260
4	A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. PubMed ·Roxana Rustomjee, Christian Lienhardt, Thomas P. Kanyok, Geraint Davies, Johannes Levin, Thuli Mthiyane, Carl Reddy, A. Willem Sturm, F A Sirgel, J Allen, David Coleman, Bernard Fourie, D A Mitchison, (unknown)	2008	230
5	Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis Antimicrobial Agents and Chemotherapy ·Roxana Rustomjee, Andreas H. Diacon, Jenny Allen, Amour Venter, Carl Reddy, R. F. Patientia, Thuli Mthiyane, Tine De Marez, Rolf van Heeswijk, René Kerstens, A. Koul, K. De Beule, P. R. Donald, D. F. McNeeley	2008	224
6	Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers The Lancet Infectious Diseases ·Robert S. Wallis, Markus Maeurer, Peter Mwaba, Jeremiah Chakaya, Roxana Rustomjee, Giovanni Battista Migliori, Ben J. Marais, Marco Schito, Gavin Churchyard, Soumya Swaminathan, Michael Höelscher, Alimuddin Zumla	2016	205
7	What We Know About Tuberculosis Transmission: An Overview The Journal of Infectious Diseases ·Gavin Churchyard, Peter Kim, Neha Shah, Roxana Rustomjee, Neel R. Gandhi, Barun Mathema, David W. Dowdy, Anne Kasmar, Vicky Cárdenas	2017	189
8	Drivers of Tuberculosis Transmission The Journal of Infectious Diseases ·Barun Mathema, Jason R. Andrews, Ted Cohen, Martien W. Borgdorff, Marcel A. Behr, Judith R. Glynn, Roxana Rustomjee, Benjamin J. Silk, Robin Wood	2017	120
9	The Early Bactericidal Activities of Rifampin and Rifapentine in Pulmonary Tuberculosis American Journal of Respiratory and Critical Care Medicine ·F A Sirgel, P. Bernard Fourie, Peter R. Donald, Nesri Padayatchi, Roxana Rustomjee, Jonathan Levin, Giorgio Roscigno, Jennifer Norman, Helen McIlleron, D.A. Mitchison	2005	83
10	Effect of Standard Tuberculosis Treatment on Plasma Cytokine Levels in Patients with Active Pulmonary Tuberculosis PLoS ONE ·Catherine Riou, Blas Peixoto, Lindi Roberts, Katharina Ronacher, Gerhard Walzl, Claudia Manca, Roxana Rustomjee, Thuli Mthiyane, Dorothy Fallows, Clive M. Gray, Gilla Kaplan	2012	76
11	Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines Antimicrobial Agents and Chemotherapy ·Helen McIlleron, Roxana Rustomjee, Mahnaz Vahedi, Thuli Mthiyane, Paolo Denti, Catherine Connolly, Wasima Rida, Alexander S. Pym, Peter J. Smith, Philip Onyebujoh	2012	73
12	A Semimechanistic Pharmacokinetic-Enzyme Turnover Model for Rifampin Autoinduction in Adult Tuberculosis Patients Antimicrobial Agents and Chemotherapy ·Wynand Smythe, Akash Khandelwal, Corinne Merle, Roxana Rustomjee, M. Gninafon, Mame Bocar Lo, Oumou Bah Sow, Piero Olliaro, Christian Lienhardt, John Horton, Peter J. Smith, Helen McIlleron, Ulrika S. H. Simonsson	2012	73
13	Treatment of tuberculosis: present status and future prospects. PubMed ·Philip Onyebujoh, Alimuddin Zumla, Isabella Ribeiro, Roxana Rustomjee, Peter Mwaba, Marcus Aurélius da Silva Gomes, John M. Grange	2005	65
14	Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction Antimicrobial Agents and Chemotherapy ·Maxwell Chirehwa, Roxana Rustomjee, Thuli Mthiyane, Philip Onyebujoh, Peter J. Smith, Helen McIlleron, Paolo Denti	2015	57
15	Transmission of drug-resistant tuberculosis in HIV-endemic settings The Lancet Infectious Diseases ·Palwasha Khan, Tom Yates, Muhammad Osman, Robin M. Warren, Yuri van der Heijden, Nesri Padayatchi, Edward A. Nardell, David Moore, Barun Mathema, Neel R. Gandhi, Vegard Eldholm, Keertan Dheda, Anneke C. Hesseling, Valerie Mizrahi, Roxana Rustomjee, Alexander S. Pym	2018	56
16	Phase 1 trial of nonoxynol-9 film among sex workers in South Africa AIDS ·Roxana Rustomjee, Quarraisha Abdool Karim, Salim S. Abdool Karim, Marie Laga, Zena Stein	1999	44
17	Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study The Lancet Infectious Diseases ·Timothy H. Holtz, Gaëtan Kabera, Thuli Mthiyane, Tainos Zingoni, Sidhambaram Nadesan, Douglas S. Ross, Jennifer R. Allen, Sekai Chideya, Henry Sunpath, Roxana Rustomjee	2011	38
18	High Rates of Potentially Infectious Tuberculosis and Multidrug-Resistant Tuberculosis (MDR-TB) among Hospital Inpatients in KwaZulu Natal, South Africa Indicate Risk of Nosocomial Transmission PLoS ONE ·Nonkqubela Bantubani, Gaëtan Kabera, Catherine Connolly, Roxana Rustomjee, Tarylee Reddy, Ted Cohen, Alexander S. Pym	2014	32
19	A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting Journal of Antimicrobial Chemotherapy ·Roxana Rustomjee	2002	31
20	A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project Trials ·Corinne Merle, Charalambos Sismanidis, Oumou Bah Sow, M. Gninafon, John Horton, Olivier Lapujade, Mame Bocar Lo, Denis A Mitchinson, Christian Perronne, Françoise Portaels, Joseph Odhiambo, Piero Olliaro, Roxana Rustomjee, Christian Lienhardt, Katherine Fielding	2012	27

About Roxana Rustomjee

Roxana Rustomjee is a scholar working on Infectious Diseases, Epidemiology, Surgery, Molecular Biology and Immunology, having authored 44 papers that have together received 4.0k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (33 papers), Pneumocystis jirovecii pneumonia detection and treatment (16 papers), Pneumonia and Respiratory Infections (10 papers), Mycobacterium research and diagnosis (9 papers), Infectious Diseases and Tuberculosis (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Biosimilars and Bioanalytical Methods (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Infectious Diseases (3.2k citations), Epidemiology (2.5k citations), Molecular Medicine (191 citations), Surgery (1.3k citations) and Microbiology (121 citations). Roxana Rustomjee has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include Jenny Allen, Sean M. O’Brien, Doris Hillemann, David Alland, Ana Milovic, Camilla Rodrigues, David H. Persing, Eduardo Gotuzzo, Catharina Boehme and Fiorella Krapp. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Lancet Infectious Diseases, The Journal of Infectious Diseases, Tuberculosis and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact